🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

Phase 2RecruitingNCT06169046

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

👨‍⚕️ Gianni Sorarù, MD, Azienda Ospedale Università di Padova📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06343090

Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients

🏥 Beijing GoBroad Hospital📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06364384

Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma

👨‍⚕️ Jun Huang, MD, Sixth Affiliated Hospital, Sun Yat-sen University📍 1 site📅 Started Apr 2024View details ↗
Enrolling by InvitationNCT06262399

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

🏥 Intellia Therapeutics📍 7 sites📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06363825

A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

👨‍⚕️ Zhong Tang, Nanping First Hospital of Fujian Province📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT07127718

Preventive Strategies for Early and Late Complications of Leptospirosis

👨‍⚕️ Romina A Danguilan, MD, National Kidney and Transplant Institute, Philippines📍 3 sites📅 Started Apr 2024View details ↗
NARecruitingNCT06382480

PROTeIn-rich Meals to Control Glucose

👨‍⚕️ Olga Ramich, PD Dr., German Institute of Human Nutrition📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT05754710

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06458660

LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence

🏥 Guiding Right, Inc.📍 3 sites📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT05849389

Vosoritide for Short Stature in Turner Syndrome

👨‍⚕️ Roopa Kanakatti Shankar, MBBS, MS, Children's National Research Institute📍 1 site📅 Started Apr 2024View details ↗
Phase 3RecruitingNCT06364631

CARE1 Pragmatic Clinical Trial

👨‍⚕️ Laurence ALBIGES, MD, PhD, Gustave Roussy, Cancer Campus, Grand Paris📍 46 sites📅 Started Apr 2024View details ↗
RecruitingNCT05700149

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

👨‍⚕️ Davide Rossi, MD, Oncology Institute of Southern Switzerland and Institute of Oncology Research📍 36 sites📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06510660

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

👨‍⚕️ Yong Yang, Doctor, Fujian Medical University Union Hospital📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06456151

Invasive Candidiasis in Critical Care

👨‍⚕️ Hana Slepčanová, Mgr., University Hospital Ostrava📍 2 sites📅 Started Apr 2024View details ↗
NARecruitingNCT05617495

Mindfulness-Based fMRI Neurofeedback for Depression

🏥 Columbia University📍 2 sites📅 Started Apr 2024View details ↗
Phase 4RecruitingNCT05821972

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate

🏥 Assiut University📍 1 site📅 Started Apr 2024View details ↗
Phase 1RecruitingNCT06251180

Phase Ib Study of Rocbrutinib in Combination with R-CHOP in Patients with Newly Diagnosed B-cell Non-Hodgkin Lymphoma

👨‍⚕️ Qingqing Cai, Ph D, Sun Yat-Sen University Cancer Center📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06275087

Differences in Speed of Recovery From Anesthesia for Intraoral Surgery

👨‍⚕️ Ivan Šitum, MD, UHC Zagreb📍 1 site📅 Started Apr 2024View details ↗
Phase 1, PHASE2RecruitingNCT05791409

Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL

🏥 Stichting Hemato-Oncologie voor Volwassenen Nederland📍 24 sites📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT05871021

Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma

👨‍⚕️ Maximilian Niyazi, Prof. Dr., University Hospital Tuebingen, Department of Radiation Oncology📍 1 site📅 Started Apr 2024View details ↗
← PreviousPage 307 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →